The Journal of Experimental Medicine
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online September 8, 2008
doi:10.1084/jem.20080072
The Journal of Experimental Medicine, Vol. 205, No. 10, 2381-2395
The Rockefeller University Press, 0022-1007 $30.00
© 2008 Shivtiel et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4843K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Shivtiel, S.
Right arrow Articles by Lapidot, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shivtiel, S.
Right arrow Articles by Lapidot, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules

Shoham Shivtiel1, Orit Kollet1, Kfir Lapid1, Amir Schajnovitz1, Polina Goichberg1, Alexander Kalinkovich1, Elias Shezen1, Melania Tesio1, Neta Netzer1, Isabelle Petit1, Amnon Sharir2,3, and Tsvee Lapidot1

1 Department of Immunology and 2 Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel
3 The Laboratory of Musculoskeletal Biomechanics and Applied Anatomy, Koret School of Veterinary Medicine, Hebrew University of Jerusalem, Rehovot 76100, Israel

CORRESPONDENCE Tsvee Lapidot: Tsvee.Lapidot{at}weizmann.ac.il

The CD45 phosphatase is uniquely expressed by all leukocytes, but its role in regulating hematopoietic progenitors is poorly understood. We show that enhanced CD45 expression on bone marrow (BM) leukocytes correlates with increased cell motility in response to stress signals. Moreover, immature CD45 knockout (KO) cells showed defective motility, including reduced homing (both steady state and in response to stromal-derived factor 1) and reduced granulocyte colony-stimulating factor mobilization. These defects were associated with increased cell adhesion mediated by reduced matrix metalloproteinase 9 secretion and imbalanced Src kinase activity. Poor mobilization of CD45KO progenitors by the receptor activator of nuclear factor {kappa}B ligand, and impaired modulation of the endosteal components osteopontin and stem cell factor, suggested defective osteoclast function. Indeed, CD45KO osteoclasts exhibited impaired bone remodeling and abnormal morphology, which we attributed to defective cell fusion and Src function. This led to irregular distribution of metaphyseal bone trabecules, a region enriched with stem cell niches. Consequently, CD45KO mice had less primitive cells in the BM and increased numbers of these cells in the spleen, yet with reduced homing and repopulation potential. Uncoupling environmental and intrinsic defects in chimeric mice, we demonstrated that CD45 regulates progenitor movement and retention by influencing both the hematopoietic and nonhematopoietic compartments.


Abbreviations used: CFC, colony-forming cell; DC-STAMP, DC-specific transmembrane protein; Erk, extracellular signal-regulated kinase; FN, fibronectin; MMP, matrix metalloproteinase; MNC, mononuclear cell; PB, peripheral blood; PYD, pyridinoline; RANKL, receptor activator of NF-{kappa}B ligand; SCF, stem cell factor; SDF-1, stromal-derived factor 1; SKL, Sca-1+/c-Kit+/Lin; Tb.N, trabecular number; TRAP, tartrate-resistant acid phosphatase; WBC, white blood cell.

© 2008 Shivtiel et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS